| Kayla Hilliard, | |
|
105 Norton Rd, Columbus, OH 43228-1713 | |
| (614) 801-8450 | |
| Not Available |
| Full Name | Kayla Hilliard |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 105 Norton Rd, Columbus, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053893842 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kayla Hilliard, 3805 Marlane Dr, Grove City, OH 43123-9224 Ph: () - | Kayla Hilliard, 105 Norton Rd, Columbus, OH 43228-1713 Ph: (614) 801-8450 |
News Archive
Olympus America Inc., a precision technology leader designing and delivering innovative solutions in medical and surgical products among other core business areas, today launched its new V-System. The new V-System combines Olympus' latest duodenoscope, the TJF-Q180V, with its unique V-System devices for the endoscopic retrograde cholangiopancreatography procedure.
Children's Hospital Boston's Pain Treatment Service has been named a "Clinical Center of Excellence" by the American Pain Society, an honor that is bestowed upon five pain centers each year. This is the first year Children's has entered into the nomination process.
Percutaneous coronary intervention (PCI), commonly known as angioplasty with a stent, opens clogged arteries and saves lives. Despite its benefit in treating atherosclerosis that causes coronary artery disease, this common minimally-invasive procedure still poses severe complications for some patients.
SNX-5422 is a heat shock protein 90 (Hsp90) inhibitor currently undergoing clinical trials as a cancer therapeutic. A recent study examines the applicability of repurposing the drug towards severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication inhibition.
Researchers at the Johns Hopkins University School of Medicine, along with colleagues at Emory University and Cedars-Sinai, have published in the journal Gastroenterology the first major, in-depth analysis of genetic risk factors of inflammatory bowel disease in African-Americans.
› Verified 2 days ago
Jennifer Withee, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 510 E North Broadway St, Columbus, OH 43214 Phone: 614-263-5151 Fax: 614-263-5365 | |
Bonnie Verhage, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5001 Farview Dr, Columbus, OH 43231 Phone: 614-797-7125 | |
Barbara E Skidmore, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 698 Morrison Rd, Columbus, OH 43213 Phone: 614-783-7708 | |
Caitlin Kelleher, M.S. CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 523 E Engler St, Columbus, OH 43215 Phone: 614-299-4554 Fax: 614-670-7427 | |
Diane M Quintana, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 510 E North Broadway St, Columbus, OH 43214 Phone: 614-263-5151 Fax: 614-263-5365 | |
Mrs. Miranda Star Walker, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 500 Morse Rd, Columbus, OH 43214 Phone: 614-468-8718 | |
Ms. Joselyn Rae Line, M.A., CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 30 Northwoods Blvd, Columbus, OH 43235 Phone: 614-545-8300 |